Rein Therapeutics (RNTX) Proxy Filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 24, 2025, with proxy voting solicited by the board of directors.

• Proxies may vote on other business that arises at the meeting, in addition to the listed proposals.

Voting matters and shareholder proposals

• Election of one Class II director, William C. Fairey, is on the ballot.

• Advisory vote to approve named executive officer compensation is included as Proposal 2.

• Board recommends voting FOR both the director nominee and executive compensation proposal.

Board of directors and corporate governance

• Proxy authorizes Brian Windsor, Ph.D., and Timothy M. Cunningham to represent shareholders at the meeting.

• Shareholders may revoke proxies in writing or by voting online during the meeting.